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Pig kidney 3,4_dihydroxyphenylalanine (dopa) decarboxylase (EC 4.1.1.28) was purified to homogeneity. Treatment of 
the enzyme with phenylhydrazine (PH) according to a procedure developed for analysis of quinoproteins gave products 
which were identified as the hydrazone of pyridoxal phosphate (PLP) and the C(S)-hydrazone of pyrroioquinoline qui- 
none (PQQ). This method failed, however, in quantifying the amounts of cofactor. Direct hydrolysis of the enzyme by 
refluxing with hexanol and concentrated HCl led to detachment of PQQ from the protein in a quantity of 1 PQQ per 
enzyme molecule. In view of the reactivity of PQQ towards amines and amino acids, we postulate that it participates 
as a covalently bound cofactor in the catalytic cycle of the enzyme, in interplay with PLP. Since several other enzymes 
have been reported to show the atypical behaviour of dopa decarboxylase, it seems that the PLPcontaining group of 
enzymes can be subdivided into pyridoxoproteins and pyridoxo-quinoproteins. 
3,4-Dihydroxyphenylalanine decarboxylase; Pyrroloquinoline quinone; Pyridoxal phosphate; Cofactor; Quinoprotein; Hydrazone; 
(Pig kidney) 
1. INTRODUCTION 
During the past few years, we demonstrated that 
many metallo-oxidoreductases are in fact metallo- 
quinoproteins: bovine serum amine oxidase [ 11, 
porcine kidney diamine oxidase [2], human placen- 
tal lysyl oxidase [3], galactose oxidase (unpub- 
lished), dopamine ,&hydroxylase [4], soybean 
lipoxygenase-1 (unpublished). The presence and 
quantity of PQQ could be established by using the 
hydrazine procedure [5], derivatizing the covalent- 
ly bound PQQ to the stable hydrazone before pro- 
tein hydrolysis was carried out. All the aforemen- 
tioned enzymes have been studied for many years, 
some of them being considered to contain Cu ions 
and pyridoxal phosphate (PLP), others to contain 
only a metal ion. Meanwhile the quinoprotein 
nature has been confirmed by other researchers. 
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Thus, the conclusion must be that the cofactor 
PQQ has been overlooked in these well-known en- 
zymes, leading to the question of whether this 
might also apply to other well-established groups 
of enzymes. 
Transaminases and amino acid decarboxylases 
have been studied for decennia and the presence or 
requirement of PLP well documented. Upon 
screening the literature, it appears, however, that 
another chromophore with an absorption max- 
imum in the 330-340 nm range is mentioned in 
several cases: rat liver ornithine aminotransferase 
(EC 2.6.1.13) [6], w-amino-acid : pyruvate amino- 
transferase (EC 2.6.1.18) from a Pseudomonas 
species [7], mammalian 4-aminobutyrate trans- 
aminase (EC 2.6.1.19) [8,9], dopa decarboxylase or 
aromatic-L-amino-acid decarboxylase (EC 4.1.1. 
28) from pig kidney [lo] and from rat liver [l 11. 
Low pH, high pH or dialysis against hydroxyl- 
amine-containing buffers removed the PLP from 
these enzymes, but not the unknown compound. 
Since the properties of the latter were strongly 
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reminiscent of covalently bound PQQ, we attemp- 
ted to prove this idea by applying the hydrazine 
method to a well-known representative of the 
aforementioned examples, namely pig kidney dopa 
decarboxylase. 
2. MATERIALS AND METHODS 
2.1. Enzyme purification and assay 
Dopa decarboxylase was purified from 430 g fresh pig 
kidneys according to [lo] with the following modifications: 
DEAE-Sepharose was used instead of DEAE-cellulose; the final 
gel filtration step on Sephadex G-100 was replaced by hydro- 
phobic interaction chromatography. The latter was performed 
on a phenyl-Sepharose CL-4B column (2 x 6 cm), equilibrated 
with 0.4 M sodium phosphate buffer, pH 6.5. Application of 
the sample and washing of the column occurred with the same 
buffer. Elution was performed with a gradient ranging from 0.4 
to 0.001 M sodium phosphate buffer, pH 6.5. 
The enzyme was assayed by a known procedure converting 
the produced dopamine into a spectrophotometrically 
measurable compound, namely method A in [ 121. 
2.2. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis was performed on gra- 
dient gels (8-25%), using the Pharmacia Phastsystem equip- 
ment according to the instructions given by the manufacturer. 
Protein staining occurred with Phastgel blue. 
2.3. Derivatization with phenylhydrazine (PH) 
Derivatization of 2 ml enzyme solution (1.1 mg/ml in 10 mM 
sodium phosphate, pH 6.5) with PH occurred under the condi- 
tions required for hydrazone adduct formation [5]. Retention 
times and absorption spectra of adducts isolated from the en- 
zyme, the model hydrazone of PQQ [5] and of PLP [13], were 
determined with HPLC and photodiode array detection [5]. 
2.4. Extraction of PQQ by the hexanol procedure 
To a solution of 10 ml enzyme (0.55 mg/mI in 10 mM sodium 
phosphate buffer, pH 6.5), 10 ml concentrated HCl and 4 ml n- 
hexanol were added. The mixture was refluxed for 4 h. After 
cooling to room temperature, the organic layer was removed 
and washed with water until the washings were neutral. The 
fluid was then evaporated using a rotary film evaporator under 
reduced pressure. The remaining solids were dissolved in 550 81 
methanol, the solution mixed with 300~1 of 10 mM sodium 
phosphate buffer, pH 6.5, and heated for 10 min at 55°C. In- 
spection for PQQ and its adducts occurred with HPLC and 
photodiode array detection [5]. The presence of free PQQ was 
also checked with a biological assay [14]. 
3. RESULTS AND DISCUSSION 
3.1. Purity of the enzyme 
The purification procedure yielded a final 
preparation which was homogeneous, as judged 
from polyacrylamide gel electrophoresis, showing 
only one band on protein staining. The band cor- 
responded to M, approx. 100000, in agreement 
with the value of M, 103 000 considered as the most 
reliable for pig kidney dopa decarboxylase [12]. 
The part of the absorption spectrum above 300 nm 
was similar to that reported by others [ 151, having 
an A333 nm/A4~~ nm ratio of 2.70 and an 
A2s0 ,JA333 nm ratio of 8.2 at pH 6.5 (unfor- 
tunately, spectra below 300 nm have not been 
published so that the latter ratio cannot be com- 
pared); 
3.2. Derivatization with PH 
In contrast to the results obtained with all quino- 
proteins investigated so far, application of the 
hydrazine method to dopa decarboxylase did not 
yield adduct on eluting the Seppak cartridge with 
methanol, but elution of coloured material re- 
quired methanol containing 0.5% (v/v) concen- 
trated ammonia. Investigation of this eluate with 
HPLC showed the presence of a multitude of col- 
oured components and the presence of two small 
peaks, denoted A and B (fig. 1). Absorption spectra 
of peaks A and B (corrected for the background) 
were identical to those of the C(S)-hydrazone of 
PQQ and PLP, respectively (fig.1). Also, the reten- 
tion times were in complete agreement with those 
of the model compounds. The amounts of the 
hydrazones obtained from the enzyme were, how- 
ever, far too low. This could either result from in- 
adequate reaction of PH with the cofactors under 
the applied conditions and uncontrolled side reac- 
tions of PH, or from insufficient proteolysis of the 
derivatized enzyme. These points are currently 
under investigation. Thus, although the hydrazine 
method demonstrated the presence of PLP and 
PQQ in the enzyme, it was unsuitable for quantify- 
ing them (of course, PLP can be determined by a 
procedure under denaturing conditions [ 131). 
3.3. The hexanol extraction procedure 
Recently we investigated galactose oxidase for 
the presence of PQQ. Since the main part of the en- 
zyme preparation has the cofactor in a reduced 
form, the hydrazine method seemed unfeasible and 
a novel method, the so-called hexanol extraction 
procedure, was developed and applied successfully 
(to be published). Briefly, the rationale behind this 
procedure is the following: the higher aliphatic 
alcohol hexanol (the high boiling point creates the 
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Fig.1. HPLC of the adducts isolated from PH-derivatized enzyme. The chromatogram (left) of the eluting species, monitored at 
350 nm, and the absorption spectra of peaks A and B (taken with the photodiode array detector at the apex of the peaks and corrected 
for background) are shown (right). 
high temperatures required for detachment of 
PQQ) forms an adduct with PQQ; the adduct 
becomes extracted into the organic solvent so that 
it escapes unwanted attack by other nucleophiles; 
the strong acid detaches PQQ or its adduct from 
the protein and protonates the carboxylic acid 
groups so that extraction becomes possible. 
Application of the procedure to the enzyme gave 
a number of compounds, as revealed by the HPLC 
chromatogram (fig.2). Peak A appeared to be 
PQQ (most probably resulting from adduct decom- 
position during the last steps in the procedure), as 
judged from identical behaviour of authentic 
material with respect o retention time and absorp- 
tion spectrum and activity in the biological assay. 
Peak B had properties identical to those of a model 
compound prepared by applying the hexanol pro- 
cedure to PQQ. Although the other peaks were not 
further investigated, they are clearly derived from 
PQQ (e.g. see the absorption spectrum of peak C in 
fig.2), the characteristics of the spectra indicating 
that the conditions during enzyme hydrolysis prob- 
ably lead to esterification or to diadduct (at the 
C(5) as well as C(4) position) formation of PQQ. 
PLP or PLP-like compounds were not observed in 
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the chromatogram, suggesting that this cofactor is 
not converted into hexanol-soluble compounds. 
This was confirmed indeed by application of the 
hexanol procedure to authentic PLP. 
3.4. Quantification of PLP and PQQ 
The quantity of PLP in dopa decarboxylase has 
been reported to be 1 PLP per enzyme molecule 
[12,15]. From the absorption spectrum of the en- 
zyme preparation in which this was determined 
[15], and using an MI of 103 000, it was calculated 
that the molar absorption coefficient of the enzyme 
at 333 nm is 6200 M-l. cm-‘. The amount of PQQ 
in the enzyme was calculated from the areas of 
peaks in an HPLC chromatogram taken at 249 nm 
(the same peaks as shown in fig.2 for 350 nm detec- 
tion), and transforming the sum of the areas into 
PQQ by using calibration values (this is allowed 
since differences in the absorption coefficients be- 
tween PQQ and its adducts or esters are negligible 
at this wavelength). From this, a quantity of 1.03 
PQQ per enzyme molecule was calculated. The 
conclusion is, therefore, that pig kidney dopa de- 
carboxylase contains 1 PLP and 1 covelantly 
bound PQQ per enzyme molecule. 
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Fig.2. HPLC of products obtained with the hexanol extraction procedure. The chromatogram (left) was taken at 350 nm and the spectra 
of peaks A-C were taken with the photodiode array detector. 
3.5. Implications 
The conclusion that dopa decarboxylase con- 
tains PQQ makes it highly probable that this also 
applies to the enzymes with a similar unknown 
compound, mentioned in section 1. It seems, there- 
fore, that PLP-containing enzymes can be sub- 
divided into pyridoxoproteins and pyridoxo-quino- 
proteins. 
Removal of PLP from dopa decarboxylase leads 
to enzyme inactivation and subsequent supplemen- 
tation with PLP to restoration [lo]. Although these 
observations how that PLP is necessary for activi- 
ty, this should not be interpreted as demonstrating 
that PQQ has a passive role. PQQ forms adducts 
with amines and amino acids [ 161 and under certain 
conditions, the adducts are very rapidly converted 
in a cyclic process ([17] and unpublished). Since 
PLP has similar chemical activities, an interplay 
between the two cofactors in the catalytic cycle is 
an attractive supposition. Anyhow, it is clear that 
interpretations of spectroscopic and mechanistic 
data concerning the group of enzymes, indicated 
here as pyridoxo-quinoproteins, should be recon- 
sidered as well as further research carried out 
before a sound proposition can be made. 
The present finding is another illustration of the 
large versatility and the wide distribution of the 
cofactor PQQ. It is also illustrative for the involve- 
ment of PQQ in the conversion or biosynthesis of 
many mammalian bioregulators, in this case being 
the cofactor of dopa decarboxylase as well as 
dopamine ,&hydroxylase, enzymes operating in the 
route of noradrenaline biosynthesis. Therefore, en- 
zymological research on quinoproteins could pro- 
vide important contributions to understanding 
physiological processes in mammals. 
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